Tag: NGS
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations...
By Kara Nyberg, PhD
Posted: June 24, 2020
Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically...
Time to End the Debate on Genomic Testing in NSCLC
By Nathan Pennell, MD, PhD
Posted: April 16, 2020
It’s an exciting time to be a thoracic oncologist. We live in an era of unprecedented discovery...
TRK Inhibition in TRK Fusion–Positive Lung Cancers
By Alexander Drilon, MD
Posted: February 12, 2020
The receptor tyrosine kinases TRKA/B/C are encoded by the genes NTRK1/2/3. TRK fusions are oncogenic drivers of various...
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
Improved Turnaround Times for Biopsy Results Matters More Than Type of Biopsy
By Dr. Edgardo S. Santos Castillero, MD, FACP
Posted: December 11, 2019
Regarding “Liquid Biopsy for Assessing...
